In this context, it is important that the expression of MMP11 and CD2 are validated as independent prognostic factors and this is in line with previous studies showing that the main gene signatures associated with prognosis in HER2+ breast cancer include genes related to tumor invasion and immune response [12, 34]. The gene discussed is ERBB2; the disease is breast cancer.